MWM
RMD icon

Moran Wealth Management’s ResMed RMD Stock Holding History

Moran Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.08M Sell
41,471
-2,176
-5% -$451K 0.22% 149
2026
Q1 		$9.8M Sell
43,647
-2,044
-4% -$509K 0.3% 111
2025
Q4 		$11M Sell
45,691
-523
-1% -$134K 0.34% 93
2025
Q3 		$12.7M Sell
46,214
-835
-2% -$228K 0.38% 84
2025
Q2 		$12.1M Sell
47,049
-188
-0.4% -$44.8K 0.37% 81
2025
Q1 		$10.6M Buy
+47,237
New +$11M 0.36% 90

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Moran Wealth Management's RMD Position: Q2 2026 in Review

Moran Wealth Management reduced its ResMed (RMD) stake by 5% in Q2 2026, selling an estimated $451K and leaving 41,471 shares worth $8.08M. The position accounts for 0.22% of the portfolio, ranked #149.

Moran Wealth Management first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $12.7M in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Moran Wealth Management held 41,471 shares of ResMed worth $8.08M as of Q2 2026.
  • Moran Wealth Management sold 2,176 ResMed shares in Q2 2026, an estimated $451K.
  • ResMed made up 0.22% of Moran Wealth Management's portfolio in Q2 2026, its #149 holding.
  • Moran Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Moran Wealth Management's ResMed position peaked at $12.7M in Q3 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.